You searched for "TUF"

45 results found

New senior appointments at The Urology Foundation

The Urology Foundation (TUF) has appointed Rebecca Porta as Chief Executive. An established and experienced charity Chief Executive, Rebecca brings a wealth of experience having held senior roles within some of the UK’s leading health and medical research charities.

BAUS Annual Scientific Meeting 2023

Day 1 Highlights by: Omer Abdalla, Urology ST6 - Wirral University Teaching Hospitals, Mersey BSoT Trainee's rep (@Omer_Uro1). BAUS 2023 began last night with a wonderful welcome reception at the Birmingham Library, where urologists from throughout the UK met again,...

The Urology Foundation – 2019 Report

It has been another busy year for The Urology Foundation in our mission to end the suffering caused by urology disease. We’ve taken big strides in some of the most crucial areas of our work as we work to prevent, treat and cure all urology disease.

Our experience: from London and Glasgow urology, to the world down under

In November 2023, we were privileged to have been hosted at the Urological Society of Australia and New Zealand’s (USANZ) annual trainee week in the beautiful city of Adelaide, South Australia. Each year, USANZ organises a week for their local...

BAUS 2023 Annual Scientific Meeting

BAUS June 2022 was certainly noteworthy for me personally, as Tim O’Brien passed on the baton of Presidency. It was also a very special meeting for everyone who participated. The event felt so refreshing after two years of COVID and...

BURST @ BAUS25

By Quentin Mak, Head of Secretariat; Aqua Asif, Head of Communications; Cameron Alexander, Co Vice-Chair; and Arjun Nathan, Co- Chair, BURST. BAUS is a cornerstone in the British Urological Researchers in Surgical Training (BURST) calendar. The conference offers BURST the...

ABU joins BCG in fight against NMIBC recurrence?

The authors test a hypothesis retrospectively in two cohorts of patients with non-muscle invasive bladder cancer (NMIBC), that endogenous bacteria in the bladder might exert antitumour effects, similar to live mycobacteria (BCG), through local immune-related or other mechanisms, on NMIBC...

Bladder cancer – an overshadowed ‘volcano’

Bladder cancer has often been overshadowed by the limelight of prostate cancer. However, of all the urological cancers, bladder cancer is the only one which has shown a slight decline in age-standardised five-year survival rates over the last couple of...

22 Weymouth Street

In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This year, 2020, is the 75th anniversary of the formation of BAUS. It...

Delivering a trainee-led Urolink educational programme – my experience in Tanzania

In May 2023, I travelled to Moshi, Tanzania, where I visited Kilimanjaro Christian Medical Centre (KCMC) – a trip which was made possible through the collaborative efforts of the British Association of Urological Surgeons (BAUS) Urolink and with the support...

Long-term oncologic outcomes of salvage cryoablation for rrPC

Of patients undergoing radiotherapy (RT) for prostate cancer (PC), at least 15-20% will experience recurrence. Although salvage prostatectomy achieves durable oncological outcomes at 10 years, it is associated with significantly high morbidity. Thus, the majority of men with radio-recurrent prostate...

Planning and doing a fellowship: advice during the COVID-19 era

To paraphrase Shakespeare, to do, or not to do a fellowship, that is the question. That may be your question; whether or not to pursue a fellowship, even more so due to the uncertainty of the COVID-19 pandemic. There are...